Brian R Keppler1, Trevor K Archer. 1. National Institute of Environmental Health Sciences, National Institutes of Health, North Carolina 27709, USA.
Abstract
BACKGROUND: Disease pathogenesis may result from genetic alterations and/or a more diverse group of epigenetic changes. While events such as DNA methylation are well established, there is significant interest in nucleosome remodeling, RNA interference and histone modifications, as mechanisms that underlie epigenetic effects. While genetic mutations are permanent, epigenetic changes can be transitory. The potential to reverse epigenetic changes has led to the development of therapeutic strategies targeting chromatin-modifying enzymes. OBJECTIVE: To review the roles of chromatin-modifying enzymes in gene regulation and to highlight their potentials as therapeutic targets. METHODS: This review is based on recently published literature and online resources. RESULTS/ CONCLUSION: This paper focuses on enzymes responsible for histone acetylation, deacetylation, methylation and demethylation, and their potential as targets for epigenetic therapies. A subsequent paper will do the same for enzymes responsible for histone phosphorylation, ubiquitylation, SUMOylation and poly-ADP-ribosylation as well as ATP-dependent nucleosome remodeling.
BACKGROUND: Disease pathogenesis may result from genetic alterations and/or a more diverse group of epigenetic changes. While events such as DNA methylation are well established, there is significant interest in nucleosome remodeling, RNA interference and histone modifications, as mechanisms that underlie epigenetic effects. While genetic mutations are permanent, epigenetic changes can be transitory. The potential to reverse epigenetic changes has led to the development of therapeutic strategies targeting chromatin-modifying enzymes. OBJECTIVE: To review the roles of chromatin-modifying enzymes in gene regulation and to highlight their potentials as therapeutic targets. METHODS: This review is based on recently published literature and online resources. RESULTS/ CONCLUSION: This paper focuses on enzymes responsible for histone acetylation, deacetylation, methylation and demethylation, and their potential as targets for epigenetic therapies. A subsequent paper will do the same for enzymes responsible for histone phosphorylation, ubiquitylation, SUMOylation and poly-ADP-ribosylation as well as ATP-dependent nucleosome remodeling.
Authors: Jeffrey C Culhane; Lawrence M Szewczuk; Xin Liu; Guoping Da; Ronen Marmorstein; Philip A Cole Journal: J Am Chem Soc Date: 2006-04-12 Impact factor: 15.419
Authors: Yu-ichi Tsukada; Jia Fang; Hediye Erdjument-Bromage; Maria E Warren; Christoph H Borchers; Paul Tempst; Yi Zhang Journal: Nature Date: 2005-12-18 Impact factor: 49.962
Authors: Santiago Ropero; Mario F Fraga; Esteban Ballestar; Richard Hamelin; Hiroyuki Yamamoto; Manuel Boix-Chornet; Rosalia Caballero; Miguel Alaminos; Fernando Setien; Maria F Paz; Michel Herranz; Jose Palacios; Diego Arango; Torben F Orntoft; Lauri A Aaltonen; Simó Schwartz; Manel Esteller Journal: Nat Genet Date: 2006-04-16 Impact factor: 38.330
Authors: Thomas A Milne; Scott D Briggs; Hugh W Brock; Mary Ellen Martin; Denise Gibbs; C David Allis; Jay L Hess Journal: Mol Cell Date: 2002-11 Impact factor: 17.970
Authors: Eric Metzger; Melanie Wissmann; Na Yin; Judith M Müller; Robert Schneider; Antoine H F M Peters; Thomas Günther; Reinhard Buettner; Roland Schüle Journal: Nature Date: 2005-08-03 Impact factor: 49.962
Authors: Marwa Matboli; Sarah El-Nakeep; Nourhan Hossam; Alaa Habieb; Ahmed E M Azazy; Ali E Ebrahim; Ziad Nagy; Omar Abdel-Rahman Journal: World J Gastroenterol Date: 2016-07-14 Impact factor: 5.742